Anita Nelsen

Anita Nelsen currently serves as President of Clinical Trial Operations at Allucent, where responsibilities include strategy, development, and execution of clinical trial operations. Prior to this role, Anita held various leadership positions at Parexel from 2015 to 2023, culminating as Executive Vice President of Translational Medicine, overseeing cross-functional strategies in genomic medicine and early phase clinical units. Experience at GSK from 2001 to 2015 involved leading teams in genetic sample management and pharmacogenetics, while earlier career roles at GlaxoWellcome and Duke University Medical Center focused on genetic research and molecular biology. Anita holds a degree from the University of North Carolina at Chapel Hill.